Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Wack

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Annual Review of Immunology|March 4, 2025
The Interplay Between Innate Immunity and Nonimmune Cells in Lung Damage, Inflammation, and RepairChrysante S Iliakis, Stefania Crotta, Andreas Wack
Current Opinion in Immunology|June 5, 2009
Immunology of TLR-independent vaccine adjuvantsEnnio De Gregorio, Ugo D'Oro, Andreas Wack
Nature Immunology|July 22, 2015
Guarding the frontiers: the biology of type III interferonsAndreas Wack, Ewa Terczyńska-Dyla, Rune Hartmann
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2015
Disease-promoting effects of type I interferons in viral, bacterial, and coinfectionsSophia Davidson, Mala K Maini, Andreas Wack
Nature Communications|May 22, 2014
Pathogenic potential of interferon αβ in acute influenza infectionSophia Davidson, Stefania Crotta, Teresa M McCabe, et al.
Nature Reviews. Immunology|June 7, 2022
Host-directed immunotherapy of viral and bacterial infections: past, present and futureRobert S Wallis, Anne O'Garra, Alan Sher, et al.
Journal of Hepatology|December 18, 2009
Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infectionStefania Crotta, Michela Brazzoli, Diego Piccioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cellsAnja Seubert, Elisabetta Monaci, Mariagrazia Pizza, et al.
Nature Reviews. Immunology|January 24, 2015
Type I interferons in infectious diseaseFinlay McNab, Katrin Mayer-Barber, Alan Sher, et al.
Vaccine|May 9, 2008
Safety of MF59 adjuvantViola Schultze, Vicente D'Agosto, Andreas Wack, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Annual Review of Immunology|March 4, 2025
The Interplay Between Innate Immunity and Nonimmune Cells in Lung Damage, Inflammation, and RepairChrysante S Iliakis, Stefania Crotta, Andreas Wack
Current Opinion in Immunology|June 5, 2009
Immunology of TLR-independent vaccine adjuvantsEnnio De Gregorio, Ugo D'Oro, Andreas Wack
Nature Immunology|July 22, 2015
Guarding the frontiers: the biology of type III interferonsAndreas Wack, Ewa Terczyńska-Dyla, Rune Hartmann
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2015
Disease-promoting effects of type I interferons in viral, bacterial, and coinfectionsSophia Davidson, Mala K Maini, Andreas Wack
Nature Communications|May 22, 2014
Pathogenic potential of interferon αβ in acute influenza infectionSophia Davidson, Stefania Crotta, Teresa M McCabe, et al.
Nature Reviews. Immunology|June 7, 2022
Host-directed immunotherapy of viral and bacterial infections: past, present and futureRobert S Wallis, Anne O'Garra, Alan Sher, et al.
Journal of Hepatology|December 18, 2009
Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infectionStefania Crotta, Michela Brazzoli, Diego Piccioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cellsAnja Seubert, Elisabetta Monaci, Mariagrazia Pizza, et al.
Nature Reviews. Immunology|January 24, 2015
Type I interferons in infectious diseaseFinlay McNab, Katrin Mayer-Barber, Alan Sher, et al.
Vaccine|May 9, 2008
Safety of MF59 adjuvantViola Schultze, Vicente D'Agosto, Andreas Wack, et al.
Pageof 9